GPER G-1 Development Group
Major Drugs - N/A, N/A, us
GPER G-1 Development Group Employees
GPER G-1 Development Group Senior Management
GPER G-1 Development Group Details
Diabetes is a growing concern globally—it is a leading cause of death and is projected to increase from 415 million diabetics in 2015 to approximately 642 million in 2040. GPER G-1 Development Group is a drug discovery and development company with the primary goal of advancing novel drug candidates that modulate the G protein-coupled Estrogen Receptor (GPER). The lead drug candidate is G-1 (Tespria™), a GPER agonist to treat obesity through weight loss, and to reverse diabetes and pre-diabetes.
Website:
gperg1.com
Employees:
5 - 9
HQ:
N/A
Location:
N/A, N/A, us
Revenue:
Not Available
GPER G-1 Development Group Technologies
Email Providers
Gmail
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly
Hosting
GoDaddy Hosting